366 related articles for article (PubMed ID: 22762129)
1. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate.
Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE
Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129
[TBL] [Abstract][Full Text] [Related]
2. Effect of risedronate on bone mass, remodelling and biomechanical strength in orchidectomized rats.
Díaz-Curiel M; de la Piedra C; Romero FI; Montero M; Gómez S; Lefort M; Carrascal MT; Phipps RJ
Horm Res; 2008; 70(2):93-9. PubMed ID: 18547956
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment with eldecalcitol (ED-71) and raloxifene improves bone mechanical strength by suppressing bone turnover and increasing bone mineral density in ovariectomized rats.
Takeda S; Sakai S; Shiraishi A; Koike N; Mihara M; Endo K
Bone; 2013 Mar; 53(1):167-73. PubMed ID: 23232307
[TBL] [Abstract][Full Text] [Related]
4. Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats.
Iwamoto J; Takeda T; Katsumata T; Tanaka T; Ichimura S; Toyama Y
Bone; 2002 Feb; 30(2):360-7. PubMed ID: 11856643
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of risedronate vs. teriparatide on bone turnover markers in women with postmenopausal osteoporosis: a randomised trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Koukoulis GN; Efstathiadou Z; Kita M; Avramidis A
Int J Clin Pract; 2008 Jun; 62(6):919-24. PubMed ID: 18422590
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis.
Li X; Ominsky MS; Villasenor KS; Niu QT; Asuncion FJ; Xia X; Grisanti M; Wronski TJ; Simonet WS; Ke HZ
Endocrinology; 2018 Jan; 159(1):260-271. PubMed ID: 29069393
[TBL] [Abstract][Full Text] [Related]
7. Effect of Combined Teriparatide and Monthly Risedronate Therapy on Cancellous Bone Mass in Orchidectomized Rats: A Bone Histomorphometry Study.
Iwamoto J; Seki A
Calcif Tissue Int; 2015 Jul; 97(1):23-31. PubMed ID: 25926046
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
Sarioglu M; Tuzun C; Unlu Z; Tikiz C; Taneli F; Uyanik BS
Rheumatol Int; 2006 Jan; 26(3):195-200. PubMed ID: 15580349
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of amlodipine on rat bone tissue after orchidectomy.
Gradosova I; Zivna H; Palicka V; Hubena S; Svejkovska K; Zivny P
Pharmacology; 2012; 89(1-2):37-43. PubMed ID: 22302040
[TBL] [Abstract][Full Text] [Related]
10. Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures.
Geoffroy V; Paschalis EP; Libouban H; Blouin S; Ostertag A; Chappard D; Cros M; Phipps R; de Vernejoul MC
Calcif Tissue Int; 2011 Jun; 88(6):464-75. PubMed ID: 21455736
[TBL] [Abstract][Full Text] [Related]
11. A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group).
Shiraki M; Fukunaga M; Kushida K; Kishimoto H; Taketani Y; Minaguchi H; Inoue T; Morita R; Morii H; Yamamoto K; Ohashi Y; Orimo H
Osteoporos Int; 2003 May; 14(3):225-34. PubMed ID: 12730746
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
[TBL] [Abstract][Full Text] [Related]
13. Grapefruit pulp increases antioxidant status and improves bone quality in orchidectomized rats.
Deyhim F; Mandadi K; Patil BS; Faraji B
Nutrition; 2008 Oct; 24(10):1039-44. PubMed ID: 18595661
[TBL] [Abstract][Full Text] [Related]
14. Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy.
Kanaji A; Higashi M; Namisato M; Nishio M; Ando K; Yamada H
Lepr Rev; 2006 Jun; 77(2):147-53. PubMed ID: 16895071
[TBL] [Abstract][Full Text] [Related]
15. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
Nakatoh S
J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
[TBL] [Abstract][Full Text] [Related]
16. Effects of risedronate on bone turnover markers in osteoporotic postmenopausal women: comparison of two protocols of treatment.
Bahlous A; Bouzid K; Sahli H; Sallami S; Abdelmoula J
Tunis Med; 2009 Jun; 87(6):380-1. PubMed ID: 19927782
[TBL] [Abstract][Full Text] [Related]
17. Anti-resorptive agents reduce the size of resorption cavities: a three-dimensional dynamic bone histomorphometry study.
Matheny JB; Slyfield CR; Tkachenko EV; Lin I; Ehlert KM; Tomlinson RE; Wilson DL; Hernandez CJ
Bone; 2013 Nov; 57(1):277-83. PubMed ID: 23988275
[TBL] [Abstract][Full Text] [Related]
18. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
19. Comparison insight dual X-ray absorptiometry (DXA), histomorphometry, ash weight, and morphometric indices for bone evaluation in an animal model (the orchidectomized rat) of male osteoporosis.
Libouban H; Moreau MF; Legrand E; Baslé MF; Audran M; Chappard D
Calcif Tissue Int; 2001 Jan; 68(1):31-7. PubMed ID: 12037621
[TBL] [Abstract][Full Text] [Related]
20. Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.
Nam SH; Jeong JH; Che X; Lim KE; Nam H; Park JS; Choi JY
Bone; 2012 Jan; 50(1):149-55. PubMed ID: 22036912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
